Lin Xiong
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers.
Journal: Human vaccines & immunotherapeutics
Published: June 12, 2025
CYP8B1 inhibits hepatocellular carcinoma progression by repressing PAK4 transcription through inhibition of nuclear translocation of u-STAT1.
Journal: Cell death & disease
Published: March 15, 2025
Diagnostic value of transesophageal echocardiography on morphology and function of left atrial appendage in patients with unclosed foramen ovale complicated with atrial fibrillation.
Journal: BMC cardiovascular disorders
Published: September 05, 2024
IGFALS suppresses hepatocellular carcinoma progression by stabilizing PPAR-γ.
Journal: International immunopharmacology
Published: July 27, 2024
Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer.
Journal: International journal of molecular sciences
Published: December 23, 2022
The application of nanoparticles in immunotherapy for hepatocellular carcinoma.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 01, 2022
Quantitative Assessment of Tumor-Infiltrating Lymphocytes Using Machine Learning Predicts Survival in Muscle-Invasive Bladder Cancer.
Journal: Journal of clinical medicine
Published: October 22, 2022
Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis.
Journal: Frontiers in molecular biosciences
Published: December 01, 2021
ROS-Related miRNAs Regulate Immune Response and Chemoradiotherapy Sensitivity in Hepatocellular Carcinoma by Comprehensive Analysis and Experiment.
Journal: Oxidative medicine and cellular longevity
Published: November 04, 2021
MicroRNA-223-3p Protect Against Radiation-Induced Cardiac Toxicity by Alleviating Myocardial Oxidative Stress and Programmed Cell Death via Targeting the AMPK Pathway.
Journal: Frontiers in cell and developmental biology
Published: October 25, 2021
HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway.
Journal: Frontiers in oncology
Published: July 10, 2021
Last Updated: 09/26/2026